YIFANG Pharmaceutical Obtain Drug registration Approval from the united Arab emirates health and prevention (MOH)
Guangdong YIFANG Pharmaceutical receive the united Arab emirates (hereinafter referred to as the united Arab emirates) department of health and prevention (MOH) approved the drug registration approval documents issued by the approval of YIFANG pharmaceutical production plant medicine e
2021.06.23
Looking forward to the performance of YIFANG Pharmaceutical in Chexpo Macao
As the key enterprise in the field of traditional Chinese medicine formula granules, YIFANG Pharmaceutical is also invited to this exhibition and the booth number is U14. Let’s look forward to the performance of us. As the key enterprise in the field of traditional Chinese medicine for
2021.03.29
YIFANG in Action to Combat COVID-19
YIFANG Pharmaceutical Approval to Achieve the "pneumonia No.1" Production within 72-hour Breakthrough of COVID-19   Guangdong YIFANG Pharmaceutical receive the united Arab emirates (hereinafter referred to as the united Arab emirates) department of health and prev
2021.03.29
YIFANG Pharmaceutical Participated in the 2nd China Chinese Medicine Industry EXPO
On August 23TH,2019, the 2nd China (Gansu) Traditional Chinese Medicine Industry Expo with the theme of "green, authentic and high quality" was held in Longxi County, Gansu Province. World Health Organization representatives, government representatives of countries along the "One Bel
2021.03.29
YIFANG Pharmaceutical Performance in 3rd Gansu Pharmaceutical Exposition
On August 28, the 3rd China (Gansu) Traditional Chinese Medicine Industry Expo and the Mission Forum of Traditional Chinese Medicine in Protecting Human Health with the theme of "Promoting the Quintessence of Traditional Chinese Medicine and Protecting Human Health" was grandly held in Lon
2021.03.29